22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › PUMA BIOTECHNOLOGY INC. › 2024-2025

PUMA BIOTECHNOLOGY INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and PUMA BIOTECHNOLOGY INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 10Ballot items
  • 149Asset managers, any item
  • 1,532Fund votes
  • June 11, 2025Meeting date

Results at a glance

Meeting of June 11, 2025: 10 items on PUMA BIOTECHNOLOGY INC.’s Form 8-K, filed June 13, 2025: 2 approved · 8 passed (calculated).

Dissent

Significant dissent: 2 directors (30.6%, 25.5% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore PUMA BIOTECHNOLOGY INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by PUMA BIOTECHNOLOGY INC.

These tallies are PUMA BIOTECHNOLOGY INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PUMA BIOTECHNOLOGY INC. — official shareholder meeting results, meeting held June 11, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Alan H. Auerbach 34,639,223---- 408,3126,521,146 99%Passed (calculated)—
Elect Director: Alessandra Cesano 26,100,362---- 8,947,1736,521,146 74%Passed (calculated)—
Elect Director: Allison Dorval 34,757,965---- 289,5706,521,146 99.2%Passed (calculated)—
Elect Director: Michael P. Miller 34,501,336---- 546,1996,521,146 98%Passed (calculated)—
Elect Director: Jay M. Moyes 34,453,681---- 593,8546,521,146 98%Passed (calculated)—
Elect Director: Adrian M. Senderowicz 34,504,501---- 543,0346,521,146 98%Passed (calculated)—
Elect Director: Brian Stuglik 34,742,184---- 305,3516,521,146 99.1%Passed (calculated)—
Elect Director: Troy E. Wilson 24,308,330---- 10,739,2056,521,146 69%Passed (calculated)—
2. The selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025 40,683,257739,693145,731 --0 98%Approved—
Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers. 32,617,8951,698,665730,975 --6,521,146 95%Approved—

Source: PUMA BIOTECHNOLOGY INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.

How asset managers voted at the PUMA BIOTECHNOLOGY INC. 2024-2025 meeting

149 asset managers disclosed a vote on at least one PUMA BIOTECHNOLOGY INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Adrian M. Senderowicz

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 34,504,501WITHHELD: 543,034

Prior year: 98.3% for (June 18, 2024 meeting) ▲ 0.2 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of directors to serve for a one-year term: Adrian M. Senderowicz

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Adrian M. Senderowicz”): 34,504,501 for, 543,034 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 10,112,240 for, 14,244 withheld, 105,823 abstained.

FOR
FOR: 10,112,240ABSTAIN: 105,823WITHHOLD: 14,244
Largest asset managers voting on “Election of directors to serve for a one-year term: Adrian M. Senderowicz” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,722,5200 00For
BlackRock1,813,7590 00For
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional410,4820 00For
SEI328,8390 00For
TARGET PORTFOLIO TRUST276,2000 00For
Federated Hermes193,7660 00For
BRIDGEWAY FUNDS INC141,3000 00For
Charles Schwab127,3120 00For
WisdomTree83,1430 00For
Equitable81,6330 00For
RBC FUNDS TRUST00 71,8000Abstain
QUANTITATIVE MASTER SERIES LLC67,0800 00For
Delaware/Macquarie61,2550 00For
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life35,8480 00For
EA Series Trust00 34,0230Abstain
Lincoln Financial32,8780 00For
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Alan H. Auerbach

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 34,639,223WITHHELD: 408,312

Prior year: 98.5% for (June 18, 2024 meeting) ▲ 0.3 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of directors to serve for a one-year term: Alan H. Auerbach

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Alan H. Auerbach”): 34,639,223 for, 408,312 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 10,218,063 for, 14,244 withheld.

FOR
FOR: 10,218,063WITHHOLD: 14,244
Largest asset managers voting on “Election of directors to serve for a one-year term: Alan H. Auerbach” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,722,5200 00For
BlackRock1,813,7590 00For
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional410,4820 00For
SEI328,8390 00For
TARGET PORTFOLIO TRUST276,2000 00For
Federated Hermes193,7660 00For
BRIDGEWAY FUNDS INC141,3000 00For
Charles Schwab127,3120 00For
WisdomTree83,1430 00For
Equitable81,6330 00For
RBC FUNDS TRUST71,8000 00For
QUANTITATIVE MASTER SERIES LLC67,0800 00For
Delaware/Macquarie61,2550 00For
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life35,8480 00For
EA Series Trust34,0230 00For
Lincoln Financial32,8780 00For
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Alessandra Cesano

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD
FOR: 26,100,362WITHHELD: 8,947,173

Prior year: 81.7% for (June 18, 2024 meeting) ▼ 7.2 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of directors to serve for a one-year term: Alessandra Cesano

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Alessandra Cesano”): 26,100,362 for, 8,947,173 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 3,803,989 for, 4,517,627 withheld, 1,910,691 abstained.

FORABSTAINWITHHOLD
FOR: 3,803,989ABSTAIN: 1,910,691WITHHOLD: 4,517,627
Largest asset managers voting on “Election of directors to serve for a one-year term: Alessandra Cesano” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard86,9860 03,635,534Withhold
BlackRock00 1,813,7590Abstain
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional410,4820 00For
SEI00 0328,839Withhold
TARGET PORTFOLIO TRUST00 0276,200Withhold
Federated Hermes193,7660 00For
BRIDGEWAY FUNDS INC141,3000 00For
Charles Schwab00 0127,312Withhold
WisdomTree83,1430 00For
Equitable6,4800 075,153Mixed
RBC FUNDS TRUST71,8000 00For
QUANTITATIVE MASTER SERIES LLC00 67,0800Abstain
Delaware/Macquarie61,2550 00For
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life15,7140 020,134Mixed
EA Series Trust34,0230 00For
Lincoln Financial32,8780 00For
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Allison Dorval

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 34,757,965WITHHELD: 289,570

Prior year: 97.2% for (June 18, 2024 meeting) ▲ 2.0 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of directors to serve for a one-year term: Allison Dorval

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Allison Dorval”): 34,757,965 for, 289,570 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 10,222,289 for, 10,018 withheld.

FOR
FOR: 10,222,289WITHHOLD: 10,018
Largest asset managers voting on “Election of directors to serve for a one-year term: Allison Dorval” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,722,5200 00For
BlackRock1,813,7590 00For
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional410,4820 00For
SEI328,8390 00For
TARGET PORTFOLIO TRUST276,2000 00For
Federated Hermes193,7660 00For
BRIDGEWAY FUNDS INC141,3000 00For
Charles Schwab127,3120 00For
WisdomTree83,1430 00For
Equitable81,6330 00For
RBC FUNDS TRUST71,8000 00For
QUANTITATIVE MASTER SERIES LLC67,0800 00For
Delaware/Macquarie61,2550 00For
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life35,8480 00For
EA Series Trust34,0230 00For
Lincoln Financial32,8780 00For
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Brian Stuglik

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 34,742,184WITHHELD: 305,351

Prior year: 98.3% for (June 18, 2024 meeting) ▲ 0.8 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of directors to serve for a one-year term: Brian Stuglik

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Brian Stuglik”): 34,742,184 for, 305,351 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 10,222,118 for, 10,189 withheld.

FOR
FOR: 10,222,118WITHHOLD: 10,189
Largest asset managers voting on “Election of directors to serve for a one-year term: Brian Stuglik” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,722,5200 00For
BlackRock1,813,7590 00For
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional410,4820 00For
SEI328,8390 00For
TARGET PORTFOLIO TRUST276,2000 00For
Federated Hermes193,7660 00For
BRIDGEWAY FUNDS INC141,3000 00For
Charles Schwab127,3120 00For
WisdomTree83,1430 00For
Equitable81,6330 00For
RBC FUNDS TRUST71,8000 00For
QUANTITATIVE MASTER SERIES LLC67,0800 00For
Delaware/Macquarie61,2550 00For
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life35,8480 00For
EA Series Trust34,0230 00For
Lincoln Financial32,8780 00For
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Jay M. Moyes

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 34,453,681WITHHELD: 593,854

Prior year: 98.2% for (June 18, 2024 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of directors to serve for a one-year term: Jay M. Moyes

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Jay M. Moyes”): 34,453,681 for, 593,854 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 10,222,118 for, 10,189 withheld.

FOR
FOR: 10,222,118WITHHOLD: 10,189
Largest asset managers voting on “Election of directors to serve for a one-year term: Jay M. Moyes” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,722,5200 00For
BlackRock1,813,7590 00For
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional410,4820 00For
SEI328,8390 00For
TARGET PORTFOLIO TRUST276,2000 00For
Federated Hermes193,7660 00For
BRIDGEWAY FUNDS INC141,3000 00For
Charles Schwab127,3120 00For
WisdomTree83,1430 00For
Equitable81,6330 00For
RBC FUNDS TRUST71,8000 00For
QUANTITATIVE MASTER SERIES LLC67,0800 00For
Delaware/Macquarie61,2550 00For
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life35,8480 00For
EA Series Trust34,0230 00For
Lincoln Financial32,8780 00For
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Michael P. Miller

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 34,501,336WITHHELD: 546,199

Prior year: 97.7% for (June 18, 2024 meeting) ▲ 0.8 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of directors to serve for a one-year term: Michael P. Miller

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Michael P. Miller”): 34,501,336 for, 546,199 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 10,112,240 for, 14,244 withheld, 105,823 abstained.

FOR
FOR: 10,112,240ABSTAIN: 105,823WITHHOLD: 14,244
Largest asset managers voting on “Election of directors to serve for a one-year term: Michael P. Miller” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,722,5200 00For
BlackRock1,813,7590 00For
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional410,4820 00For
SEI328,8390 00For
TARGET PORTFOLIO TRUST276,2000 00For
Federated Hermes193,7660 00For
BRIDGEWAY FUNDS INC141,3000 00For
Charles Schwab127,3120 00For
WisdomTree83,1430 00For
Equitable81,6330 00For
RBC FUNDS TRUST00 71,8000Abstain
QUANTITATIVE MASTER SERIES LLC67,0800 00For
Delaware/Macquarie61,2550 00For
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life35,8480 00For
EA Series Trust00 34,0230Abstain
Lincoln Financial32,8780 00For
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Troy E. Wilson

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

69% Majority: yes · of votes cast

FOR 69%WITHHELD
FOR: 24,308,330WITHHELD: 10,739,205

Prior year: 78.4% for (June 18, 2024 meeting) ▼ 9.1 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of directors to serve for a one-year term: Troy E. Wilson

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Troy E. Wilson”): 24,308,330 for, 10,739,205 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 69% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 3,359,977 for, 4,855,816 withheld, 2,016,514 abstained.

FORABSTAINWITHHOLD
FOR: 3,359,977ABSTAIN: 2,016,514WITHHOLD: 4,855,816
Largest asset managers voting on “Election of directors to serve for a one-year term: Troy E. Wilson” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard86,9860 03,635,534Withhold
BlackRock00 1,813,7590Abstain
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional410,4820 00For
SEI00 0328,839Withhold
TARGET PORTFOLIO TRUST00 0276,200Withhold
Federated Hermes00 0193,766Withhold
BRIDGEWAY FUNDS INC141,3000 00For
Charles Schwab00 0127,312Withhold
WisdomTree83,1430 00For
Equitable00 081,633Withhold
RBC FUNDS TRUST00 71,8000Abstain
QUANTITATIVE MASTER SERIES LLC00 67,0800Abstain
Delaware/Macquarie00 061,255Withhold
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life15,7140 020,134Mixed
EA Series Trust00 34,0230Abstain
Lincoln Financial3,3780 029,500Mixed
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 32,617,895AGAINST: 1,698,665

Prior year: 95.7% for (June 18, 2024 meeting) ▼ 0.6 pts

Details: description as filed, official tally, votes by 149 asset managers

Description as filed by funds: ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE PROXY STATEMENT.

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers.”): 32,617,895 for, 1,698,665 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 57 asset managers voting on “ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED EXECUTIVE OFFICERS” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,722,5200 00For
BlackRock1,813,7590 00For
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional0410,482 00Against
SEI328,8390 00For
TARGET PORTFOLIO TRUST276,2000 00For
Federated Hermes193,7660 00For
BRIDGEWAY FUNDS INC0141,300 00Against
Charles Schwab127,3120 00For
WisdomTree83,1430 00For
Equitable81,6330 00For
RBC FUNDS TRUST71,8000 00For
QUANTITATIVE MASTER SERIES LLC67,0800 00For
Delaware/Macquarie61,2550 00For
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life35,8480 00For
EA Series Trust34,0230 00For
Lincoln Financial29,5003,378 00Mixed
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Fund voting reports, all 57 managers: 9,648,871 for, 576,827 against, 10,018 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 111 asset managers voting on “ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED EXECUTIVE OFFICERS” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,491,8770 00For
American Century1,199,5170 00For
GEODE CAPITAL MANAGEMENT, LLC967,0970 00For
Renaissance810,2280 00For
KENNEDY CAPITAL MANAGEMENT LLC638,59496,405 00Mixed
State Street595,8192,376 00For
DE Shaw513,2420 00For
GLOBEFLEX CAPITAL L P390,2720 00For
SEI336,3960 00For
Connor, Clark & Lunn Investment Management Ltd.295,4970 00For
Prudential/PGIM289,8350 00For
Eversept Partners, LP275,7880 00For
MARSHALL WACE, LLP275,5650 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP224,1330 00For
Two Sigma222,2850 00For
Northern Trust210,9190 00For
Federated Hermes198,8190 00For
Newton Investment Management North America, LLC160,8000 00For
MACKENZIE FINANCIAL CORP157,7130 00For
O'SHAUGHNESSY ASSET MANAGEMENT, LLC143,3867,436 00For
BRIDGEWAY CAPITAL MANAGEMENT, LLC0149,100 00Against
STRS OHIO141,9000 00For
MELLON INVESTMENTS Corp137,8820 00For
Fidelity128,4430 00For
Charles Schwab127,3190 00For

Institutional-manager reports, all 111 managers: 10,863,475 for, 463,896 against, 120 abstained. Showing the 25 largest; every one is in the interactive database (link above).

The selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December…

Official resultAUDIT-RELATEDReported outcome: Approved

98% Approved · of votes cast

FOR 98%
FOR: 40,683,257AGAINST: 739,693

Prior year: 99.0% for (June 18, 2024 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: RATIFICATION OF THE SELECTION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF PUMA BIOTECHNOLOGY, INC. FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

PUMA BIOTECHNOLOGY INC.’s own tally for this item (“2. The selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025”): 40,683,257 for, 739,693 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: The Company's stockholders ratified the selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 10,046,149 for, 179,549 against, 10,018 abstained.

FOR
FOR: 10,046,149AGAINST: 179,549ABSTAIN: 10,018
Largest asset managers voting on “RATIFICATION OF THE SELECTION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF PUMA BIOTECHNOLO” at PUMA BIOTECHNOLOGY INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,722,5200 00For
BlackRock1,813,7590 00For
American Century1,176,3540 00For
Fidelity1,059,1270 00For
Dimensional410,4820 00For
SEI328,8390 00For
TARGET PORTFOLIO TRUST276,2000 00For
Federated Hermes193,7660 00For
BRIDGEWAY FUNDS INC0141,300 00Against
Charles Schwab127,3120 00For
WisdomTree83,1430 00For
Equitable81,6330 00For
RBC FUNDS TRUST71,8000 00For
QUANTITATIVE MASTER SERIES LLC67,0800 00For
Delaware/Macquarie61,2550 00For
TIAA55,9220 00For
GPS Funds I43,2800 00For
Virtus41,6140 00For
Goldman Sachs40,1140 00For
Pacific Life35,8480 00For
EA Series Trust034,023 00Against
Lincoln Financial32,8780 00For
Legg Mason32,6900 00For
Putnam31,2460 00For
Exchange Place Advisors Trust27,5460 00For

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

Largest PUMA BIOTECHNOLOGY INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 49,638,093 shares outstanding at the time of that meeting.

Fund voting reports: top PUMA BIOTECHNOLOGY INC. shareholders by shares voted on “ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 7.50%
2BlackRock 3.65%
3American Century 2.37%
4Fidelity 2.13%
5Dimensional 0.83%
6SEI 0.66%
7TARGET PORTFOLIO TRUST 0.56%
8Federated Hermes 0.39%
9BRIDGEWAY FUNDS INC 0.28%
10Charles Schwab 0.26%
Institutional-manager reports: top PUMA BIOTECHNOLOGY INC. shareholders by shares voted on “ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED…”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 3.01%
2American Century 2.42%
3GEODE CAPITAL MANAGEMENT, LLC 1.95%
4Renaissance 1.63%
5KENNEDY CAPITAL MANAGEMENT LLC 1.48%
6State Street 1.21%
7DE Shaw 1.03%
8GLOBEFLEX CAPITAL L P 0.79%
9SEI 0.68%
10Connor, Clark & Lunn Investment Management Ltd. 0.60%

Reported PUMA BIOTECHNOLOGY INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

PUMA BIOTECHNOLOGY INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Anders Hove3,940,052 7.94%Schedule 13G, filed February 14, 2025
BlackRock3,847,368 7.75%Form 13F, quarter ended March 31, 2025
Vanguard Group3,669,263 7.39%Form 13F, quarter ended March 31, 2025
Renaissance Technologies1,829,213 3.69%Form 13F, quarter ended March 31, 2025
Millennium Management1,385,194 2.79%Form 13F, quarter ended March 31, 2025
Geode Capital955,456 1.92%Form 13F, quarter ended March 31, 2025
Dimensional Fund Advisors888,663 1.79%Form 13F, quarter ended March 31, 2025
State Street649,792 1.31%Form 13F, quarter ended March 31, 2025
D.E. Shaw571,665 1.15%Form 13F, quarter ended March 31, 2025
BNY Mellon340,886 0.69%Form 13F, quarter ended March 31, 2025

Percentages above are of 49,638,093 shares outstanding, as reported by PUMA BIOTECHNOLOGY INC. on its Form 10-Q dated May 5, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At PUMA BIOTECHNOLOGY INC.'s shareholder meeting held June 11, 2025, in the 2024-2025 proxy season, 149 asset managers reported votes on at least one of its 10 ballot items in their SEC Form N-PX filings, covering 1,532 separate fund positions. On the most widely held item on that ballot — ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED… — PUMA BIOTECHNOLOGY INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: PUMA BIOTECHNOLOGY INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PUMA BIOTECHNOLOGY INC.’s 10-Q dated May 5, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

PUMA BIOTECHNOLOGY INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “PUMA BIOTECHNOLOGY (PBYI) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/puma-biotechnology-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.